4.600SEK-7.26%Mkt Cap: 723.19M SEKP/E: —Last update: 2026-06-01
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The compa…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap723.19M SEK
Enterprise Value746.22M SEK
Revenue (TTM)103.76M SEK
Gross Profit34.69M SEK
Net Income (TTM)-137.42M SEK
Revenue/Share0.6780 SEK
Last Price4.600 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees59
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-16.53
PEG—
EV/EBITDA-6.32
EV/Revenue7.19
P/S7.52
P/B2.56
EPS (TTM)-0.87
EPS (Forward)-0.30
52W Range
3.85021% of range7.380
52W High7.380 SEK
52W Low3.850 SEK
Profitability
Gross Margin33.35%
Oper. Margin-111.42%
EBITDA Margin-113.87%
Profit Margin-132.11%
ROE-45.14%
ROA-37.03%
Growth
Revenue Growth-1.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-109.10M SEK
CapEx (TTM)18.10M SEK
FCF Margin-63.15%
FCF Yield-9.06%
Net Debt-33.56M SEK
Net Debt/EBITDA0.28
Balance Sheet
Debt/Equity0.05
Current Ratio3.76
Quick Ratio2.67
Book Value/Sh1.937 SEK
Cash/Share0.3520 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.500 SEK
Target Range9.500 SEK – 9.500 SEK
# Analysts1
Ownership
Shares Out.157.22M
Float107.65M
Insiders47.08%
Institutions18.78%
Technical
SMA 504.602 (-0.0%)
SMA 2005.226 (-12.0%)
Beta0.38
S&P 52W Chg27.70%
Avg Vol (30d)251.38K
Avg Vol (10d)184.43K
Technical Indicators
RSI (14)58.7
MACD0.0041
MACD Signal-0.0265
MACD Hist.+0.0306
BB Upper4.836 SEK
BB Middle4.596 SEK
BB Lower4.355 SEK
BB Width10.46%
ATR (14)0.2849 SEK
Vol Ratio (20d)4.65x